SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-16-520317
Filing Date
2016-03-29
Accepted
2016-03-29 06:06:34
Documents
12
Period of Report
2015-12-31

Document Format Files

Seq Description Document Type Size
1 20-F d160947d20f.htm 20-F 1294877
2 EX-12.1 d160947dex121.htm EX-12.1 7995
3 EX-12.2 d160947dex122.htm EX-12.2 7974
4 EX-13.1 d160947dex131.htm EX-13.1 4700
5 EX-15.1 d160947dex151.htm EX-15.1 2473
6 GRAPHIC g160947g12b69.jpg GRAPHIC 140202
7 GRAPHIC g160947g34h96.jpg GRAPHIC 131613
8 GRAPHIC g160947g45z76.jpg GRAPHIC 207772
9 GRAPHIC g160947g56q48.jpg GRAPHIC 68883
10 GRAPHIC g160947g71z06.jpg GRAPHIC 178016
11 GRAPHIC g160947g83a57.jpg GRAPHIC 53444
12 GRAPHIC g160947g83d02.jpg GRAPHIC 28717
  Complete submission text file 0001193125-16-520317.txt   2433154
Mailing Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376
Business Address 6 JONATHAN NETANYAHU ST. OR YEHUDA L3 60376 972-3-6346450
Vascular Biogenics Ltd. (Filer) CIK: 0001603207 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 20-F | Act: 34 | File No.: 001-36581 | Film No.: 161533528
SIC: 2834 Pharmaceutical Preparations